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ABSTRACT

This paper presents the insight that R&D investments are "natural" op-

tionM , and examines the extent to which they can be valued using currently
Available option pricing models.

The nature of the industrial research effort

determi nes whether the appropriate model is based on a diffusion process or a
jump proc ess.

The option model based on the former is sufficiently developed

to eatisfac torily deal with the direct benefits of R&D, while the model based

on t he l atter presents several problems.

not captured in these models.

Furthermore, indirect benefits are

These applications and shortcomings are ex-

amined in deta il in the hope of not only indica ting a new direction f or analy111 of R&D investment decisions, but also pointing out the need for further

IChola rly research to deal more fully with this very interesting problem.

BUDGETING CAPITAL FOR R & D:

AN APPLICATION OF OPTION PRICING

Introduction:
Deciding where and how much to invest in industrial research and development is not only a very interesting problem, but also one of great importance-- in 1977 the total U. S. R&D pricetag topped $40 billion.!

In 1976 the

top three private spenders -- General Motors, IBM, and Ford -- alone accounted
for $3.2 billion.2

R&D investment is big, and it is hard to picture a vital,

dynamic economy without such venturing.
We have ample evidence that there is a systematic relationship between
profitability and the level of committment to R&D;3 however, there is a serious shortcoming in the way of rigorous methods to show what level is best for
a particular situation, as even the most sophisticated optimization models
suffer when benefit estimates are soft.4
There are several mathematical models available, some very complex, for
optimizing the R&D project mix, but as pointed out by Baker & Freeland [4] in
their review of the literature, measuring the benefits from R&D is a critical
area for further research.

The best of the available approaches depend on an

estimate of cash flows from the successful project.

However, it is difficult

or impossible to analysis R&D expenditure using any of the standard capital
budgeting techniques which discount expected future cash flows from the project.

The very reason for research is that much is unknown about the fledg-

ling product or technology; for example, it might be unreasonable to make an
estimate of cash flows prior to embarking on research into, say, commerical
applications of solar-powered electric generation.

Even if such estimates

were made, it would be equally difficult to estimate the appropriate required
rate of return to be used as the decision criterion.

In many cases it is
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difficult to confidently estimate an appropriate beta, or deal with the correlations between the new project and existing projects within the firm's portfolio.

Moreover, it is the nature of research that new information is being

sought which may have a profound impact on the value of the project.
What is being bought with research money is opportunity -- opportunity to
exploit any marketable results of the research.

In its simplest aspect, the

decision facing the business strategist is whether or not the value of the opportunity exceeds the cost.

Fortunately, a tool exists which may allow the

nece ssa ry cost-benefit compari son to be made in a disciplined way:
Pricing Model (OPM).

the Option

An R&D opportunity is a "natural" option; the funding of

research is the purchase of an option to exploit any product which might result.
Discussion of the Problem:
Consider the executive faced with deciding whether to fund a particular
proje ct .

He probably has fairly reliable estimates of the cost of research,

but no guarantee that any return will come from "casting his bread upon the
waters. "

If the potential is great enough, he will give the go-ahead knowing

that if only one out of every ten of thes e high-flyers pays off, the company
will still come out ahead.

He also knows that if the bu siness doe s n't take

risks, it will go stale.
The direct benef it from a successful R&D effort would come from the opportunity to exploit a new pr oduct with competition held at bay by patents or
delays in developing their own substitutes.
tion.

This can be dealt with as an op-

The option framework is intuitively a very attractive place to look f or

a s olution, as the decision face d by the exec utive above is similar to that
faced by an investor c onsidering purchase of a call option.

The exe cut ive
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mu1t pa y a price to get into a game in which there may be no payoff at all;
however , the attraction is the chance for a really big payoff.
The price of conducting research buys the investor the opportunity to ex-

ploi t a ny product which might result, and can be thought of as an option to
make a n investment in production.

This concept could be modeled in such a way

that the underlying thing of value is the present value of revenues from producti on, the exercise. price is the cost of initiating production, and the expira t i on date is the time the money runs out from the initial research investment .

Although this approach raises the complication of a stochastic exercise

pri c e , the problem is addressable in a straight-forward manner as shown by
Stanley Fischer [18].
An appropriate model would incorporate an initial cost of the option
e qual to the present value of the cost of conducting research over a particu:....
lar period of time, discounted at the risk-free rate;S an expiration date coi nc i ding with exhaustion of the fund set up by the initial investment, as well
as a n underlying thing of value and exercise price which follow stochastic
processes through time.

Upon exhaustion of the original money invested, fur-

t he r research or development might appear attractive; and this could be treate d as a separate investment in a new option.
The decision variables for executives are the size of the initial investme nt and the length of time to be funded at each decision point (in other
wor ds, the number of times the research effort must be reevaluated).
Initiating product research is the setting in motion of an informationgathering process.

At the outset, the research management team brings to bear

a ll the currently available information about the prospects for the research,
and this information is reflected in their initial estimate of the project's
value.

Once research is under way, new information surfaces continuously and
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the value estimate is revised accordingly.

It is a matter of uncertainty ex-

actly where the research will lead, but the range of

uncertainty~

be esti-

mated ahead of time and the process modeled statistically.
The option investor however can do something our corporate executive cannot so easily do -- the option investor can hedge.

By judiciously selling

short the underlying stock, the holder of a call option can theoretically eliminate risk altogether.

However, when the underlying thing of value is an un-

developed product or technology, such hedging is not available.
important primarily from the standpoint of modeling.

This point is

Many, perhaps most, op-

tion investors play the game because options offer them a way to take the high
levels of risk that justify the long-run expectation of high reward.
folks are not interested in forming riskless hedges.

These

However, the possibility

of doing so allows arbitrage, and the hedge is key to the Black-Scholes market
equilibrium solution to the value of an option.
Although the stochastic calculus used in the OPM is sophisticated, the
basic idea is simple.

Because there is a direct relationship between the val-

ue of a call option and the value of its underlying security, there is perfect
negative correlation between returns to a call and returns to a short position
in the stock.

It is theref ore possible to form a riskless hedge position, and

in capital market equilibrium the return on the hedge must be the same as the
return on other risk- free investments.

By expressing this hedge in a dynamic

continuous time set of equations, Black and Scholes [6] were able to derive a
solution for the value of the call option.

The finance literature contains

several good reviews of option pricing, for the reader interested in full details. 6
The lack of hedging opportunit i es puts the R&D exe cutive's proble m in a
different light; the company will not necessarily have to pay the full
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equilibrium value to get in on the action.

Not only is the company not buying

into the gamble on an active and efficient securities market, but even if that
were the case, there would be no opportunity for arbitrageurs to enforce the
going market reward for risk by the method of forming hedges.

The option

pricing model is nevertheless applicable, because the active option market
represents an alternative opportunity to provide risk-bearing services of the
same kind.

The OPM can give insight into what the market equilibrium value

should be for a particular venture, and if it could be bought for that amount
or less, it would be a good investment.
Diffusion Process Models:
The assumptions made at the outset (about the appropriate stochastic process underlying the project value) determine which option pricing model will
be used.

Research intended to improve on an existing product or process might

fit into the framework of a diffusion process.

The essence of a diffusion

process is that it represents a continuous random walk around a trend and, at
least in the short run, seldom offers sudden surprises.

The basic assumption

of the Black-Scholes OPM is that the value of the underlying security follows
a log-normal diffusion process expressed as,
(1)

where S is the value of the underlying security,

~

is the drift term, as is

the instantaneous standard deviation around the drift, and dzs is a Weiner
process.

A Weiner process describes Brownian motion, which can be illustrated

by the movement of a very small particle suspended in a fluid and bombarded at
random by moving molecules.

Each movement is small, the bombardment is con-

tinuous, and the two- dimensional analogue of the path is a random walk.
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There are many research projects whose value would change through time in
the same way.

This would be the case if the product or process being

researched were already well-developed, the goal of the research well-defined,
and the obstacles to be overcome fairly well-known in advance.
of R&D money is spent on such projects.?

The majority

In short, such research would be

expected to produce a steady upward trend, with random shocks along the way
which individually would most likely be small.

In the short run, no great

surprises would be expected; but even so, the final outcome could not be known
in advance with certainty.
The nature of the random shocks themselves is worth further discussion.
Random upward boosts of course could result from fortuitous discoveries, and
unforeseen bottlenecks could produce downward shoves of enough magnitude to
dampen or cancel out the upward drift.

Would it, however, be realistic to

leave the model free to capture an actual decline in the value of the product
or process?

In other words, it seems fair to ask whether the time path should

be restricted to upward movement only.

It could be possible that the research

would reveal previously unknown flaws in the idea, and it is also desireable
to allow for external events (such as competition or the possibility of prQduct liability suits) which could have an adverse impact on the value of the
product.

It therefore seems reasonable to leave as is the specification pre-

sented in equation (1).
From equation (1), Black and Scholes developed a formula for the equilibrium value of a call option with a known exercise price.

If the cost of im-

plementing the changes resulting from the research (the striking price for exercising the research option) were known with certainty beforehand, the basic
Black-Scholes model could be used unmodified.

It is stated as follows:

t
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call option price
current stock price
exercise price
default-free interest rate
instantaneous variance of return on the stock
time to expiration
cumulative normal distribution function

However, it may be more realistic to suppose that the exer_c ise price is
In such a case it would be possible to

not known with certainty beforehand.

make an initial estimate of it, with st·ochastic changes anticipated.

In the

case where the exercise price also follows a diffusion process, a solution exists as presented by Stanley Fischer [18].

Where new information impacting on

the initial estimate of exercise price is assumed to come in random, continuous small jolts, the process generating the time path for it could be described by the following equation:
(3)

where X is the exercise price, ax is a drift term, crx is the instantaneous
standard deviation, and dzx is a Weiner proc ess.
In the R&D case, it would be valid to assume that no drift would be
expected, so that ax would be zero.

Modifying Fischer's equation accordingly,

the market equilibrium value would be,
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The parameter a

tiona! variance of change in the ratio (S/X).

is the instantaneous proporThe parameter rh is the rate of

return on the (possibly imaginary) security used to hedge away the risk from
the fluctuating exercise price.

The expected return on this hypothetical se-

curity would be given by:
rh

=

r + b

(5)

where r is the risk-free rate and b is the appropriate risk premium.

Applying

the Capital Asset Pricing Model to establish the appropriate value for b results in the following:

( 6)

where

t~e

subscript m denotes the market as a whole.

is also zero.

Thus, when

Pmx

=

0, b

In most cases of R&D, the correlation between random shocks to

the stock market and random shocks to the exercise price would be nonexistent.
That is, the risk associated with the exercise price in the R&D case is in all
likelihood based on technological uncertainties which are completely unsystematic and therefore diversifiable.8

Thus, rh would be , in this case, the

risk-free rate.
It may be that in the real world, opportunities do not exist to form the
hedges assumed in the derivation of the option pricing models; nevertheless,
the models are valuable and applicable.

f
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Surely the basic justification for the existence of a business organization is that it can exploit imperfections in the markets for goods and
services which the individual investor cannot do alone.

Unless the managers

can find investments which offer a return to risk ratio at least as favorable
as that available to the capital market investor, the organization cannot pay
the freight and will not long exist.

Security valuation models can therefore

be used as a benchmark for evaluating the corporation's investments, in that
they show the appropriate reward for a given kind and level of risk.
The wide availability of software for the Black-Scholes OPM (even for
hand-held calculators) makes its adaptation for estimating the benefits from
R&D projects very attractive.

It is a model with a proven track record, which

is reassuring to decision-makers.

To set up for its use, the analyst needs

estimates of only seven inputs:

s

= an initial estimate of the present value of cash flows from

the product or process to be developed
X

= an initial estimate of the cost of undertaking production

r

= the risk-free interest rate

as = the

instantaneous standard deviation around the trend line for S

ax

= the

standard deviation around the trend line for X

Psx

= the

correlation between random shocks to S and X

T

= time

to expiration of the research effort

These estimates could be made subjectively for each project, or objectively on
the basis of historical data for similar projects previously undertaken.

The

making of these estimates, especially that for S, interfaces the model with
the expertise of the R&D planning staff.

The inability of existing mathemati-

cal models to do this adequately has been an area of past criticism.9
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Not only is equation (4) useful for estimating the value of initiating
research, it can also give insight into the decision about the length of time
for which the research should be funded.

One of the results from option pric-

ing theory is that the value of the option increases the longer the time to
expiration.10

Intuitively, this can be explained because the longer the time

the process has in which to operate, the greater the potential spread between
exercise price and the value of the underlying security.

~~nagers

could use

the model to see the results of various decisions about T, and could choose
accordingly.
An Implication of the Diffusion Model
One remarkable fact from option pricing theory is that because of the
limited liability of the option (so that the downside is truncated) the option
is more valuable the higher the variance of return on the und e rlying security.
Increasing the variance, ceteris paribus, means an increase in upside potential, but the limited liability prevents downside risk from increasing proportionately -- thus the increase in the value of the option.
the R&D

~ield,

Translated into

this means that the greater the uncertainty about what the re-

search will discover, the greater the value of that research.

The somewhat

troubling implication which naturally follows is that so long as this holds
true, society need have little worry about the prospects for continued technological progress.

This runs contrary to the malaise perceived by many to be

currently afflicting industrial research in the United States.
Barring an unlikely lack of research opportunities (resting on the foolish notion that there is little left to invent), the malaise could be traced
within the confines of the model to low perceived value for the underlying
securities.

This would be the natural result of long delays imposed by
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government regulatory bodies between the time research has produced a product
and the time that product can be marketed.

In the drug industry, for example,

such delays are necessary for testing the safety of new drugs.

Also of con-

cern would be a political climate hostile to the apparently large profits of
successful development efforts, which is an especially important possibility
in the fields of food, fuel, and medicine.

Finally, the increased risk of

product liability litigation in the current business environment certainly
adds a dimension capable of greatly reducing the expected value of going ahead
with production, therefore reducing the incentive for research.
In order for a society to progress, it is necessary that risks be taken,
and that risk-takers be rewarded.

During the formative years of this nation,

large numbers of very ordinary people were willing to take the ultimate risk
necessary to settle the frontiers.

Progress depends not only on the taking of

financial risks, but also on the taking of technological and even physical
risks.

Those willing to bear these risks serve an essential role, and are

compensated by the hope of a better life.

Yet, as more people share in a

high-quality life, it may be that fewer are willing to bear non-financial
risk; and we more often call into question the fairness of the circumstances
out of which such risk-taking arises.
Not only business firms, but also governments and nations must be competitive.

It is to be expected that the less risk-averse groups will be the

centers of innovative activity, and that they will tend to progress more rapidly.
The Problem of Indirect Benefits
The benefits from R&D are complex and subtle.

Besides the direct bene-

fit, indirect benefits from an ongoing R&D effort could come from chance
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discoveries or perhaps more importantly from the know-how in place to re s pond
to breakthroughs in technology achieved elsewhere.

Becau se the option model

just presented does not capture the s e indirect benefits, it is possible that
research proje cts which should be a cce pted would be erroneou s ly reje cted if
the OPM were used as the sole criterion.
Another intere st ing problem with indirect benefits c oncerns the model's
basic underlying a ss umption about the value of the information whi c h creates
the c hanges in t he pri c e of the und erlying s ec urity.

W"h e n deali ng with

stocks, the use of a log-normal diffu s ion process grows out of the assumption
of an efficient market, within which the sec urit y ' s pri ce changes in respon s e
to new information (whi c h c omes at random).

On ce the n ew information ha s been

captured in the price of the underly ing stock, the information has no more
value.

The initiation of indu s trial research se t s in motion a s imilar inf or-

mation generating pro c ess and th is information adj u sts the e s timated value of
the underlying sec urit y , but it i s not necessaril y true that the inf ormation
then be c ome s worthles s .

Any re sidual value o f the information is another in-

direct ben efit not c aptur e d in s traight f orwar d appli ca tion o f the OPM to the
R&D problem.

If the v alue o f direct benefit s were e noug h to j u s ti fy the ini-

tiation of research, c ons ideration o f indirect benefit s would be a moot point
for the de cisi on-maker (although not f or the sec uritie s anal ys t).

From the

d ecisi on-maker's point of v iew, the OPH ca n onl y give a c lear "go" indi c ation
for the R&D de cis ion, but cannot be relied upon alone f or a "no-go" choice.
Even though the probl em of indi rect be ne f it s thu s limit s it s u sef ulne ss , the
OPM still can gi ve a c lear indi cat ion in one di rec t i on, and s o is not without
value in a pp licat ion t o the R&D proble m.
capture s more o f

Mo re ov er , d e s pite it s d ra wba c k s , it

the value o f R&D than any of the di sc ount e d c a s h fl ow te c h-

niques whi c h repr esent the c urrent s tate-of -the-art.
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Placing a value on these indirect benefits is a pregnant area for further
scholarly research.
Problems with the Jump Process Model:
In the framework of the diffusion process, it is possible to deal with
situations characterized by slow, steady change.

There are no sudden leaps

expected, although they can occur and are allowed for in the variance of the
diffusion process (although most moves cluster around the mean, allowance is
implicitly made for the occassional very large jump).

There are R&D situa-

tions, however, in which sudden leaps are the essence rather than the exception.

In fact, the exciting projects dealing with things on the frontiers of

science and technology would not fit very neatly into the diffusion process
scenario.

In this exciting world of high-technology research, days -- even

weeks -- can go by with no apparent progress; then suddenly a barrier comes
down and a great leap is accomplished in but a moment of time.

There is a

continuous time stochastic process, the jump process, which captures this.
Unfortunately, application of the available jump process option model to R&D
is much less satisfying than application of diffusion process models.
Cox and Ross [14] have worked out market equilibrium solutions to option
values under a variety of stochastic processes, including jump processes.

If

x denotes the current state of the world, then a general form for a Markov
jump process can be stated as:

dS =

J.l

(x)dt +

<

A

(x)dt

1 -A (x)dt

k (x) -1,
0

(7)

Notation:
drift term

J.l (x)

A (x)

= probability

k(x)-1

=

of jump during time interval dt, or the process
intensity
jump amplitude
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Cox and Ross showed that the diffusion process of equation (1) is actually a special case of the more general process of equation (7).

Unlike the R&D

scenario which fit equation (1), the case now being dealt with is one which
contains no drift.
progress.

As noted above, a long time may go by with no apparent

Thus, the drift term would drop out.

However; several other, more

restrictive assumptions are necessary to derive a workable solution.

By as-

suming that any discoveries would be good news, the jump direction would have
to be up and the term [k(x) - 1] can be confined to positive values.
necessary to prevent violation of the limited liability condition.

This is
Further,

if it were assumed that all knowledge about the current state of the world
were captured in the initial estimate of the project's value, S, then A.(x) and
k(x) could be restated as A.(S) and k(S).

Finally, if the process intensity

A.(x) were specialized to be proportional to S, A.S, and the amplitude assumed
to be independent of S, the process would be refined to one for which Cox &
Ross have accomplished a market equilibrium solution.

It is a pure birth pro-

cess without drift,
A.Sdt

k-1,

dS

o.

( 8)

Unfortunately, a solution has not yet been found for the situation in which
the jump amplitude can take more than one value, because it greatly complicates formation of the hedge necessary to specify the market equilibrium condition, and because it allows the possibility that the limited liability constraint might be violated.

Even so, theLe is no practical difference between

a single large jump and a rapid-fire series of small jumps, which could occur
under the above specification.

The valuation formula derived under the pure

birth process is given by Cox & Ross as follows:
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Notation:
C

value of option

S

value of underlying security

X

exercise price

k

=

T

jump amplitude
time of expiration

t

= current

r

= risk-free rate

B(j;p,q)

time

the negative binomial distribution, with
( j-1) qP (1-q)j-p
p-1
values for j and p adjusted to the largest integer not exceeding the orginal value.

To implement the use of this technique, the analyst would need point estimates for S,X,k, and r based on the best currently available knowledge.

Un-

fortunately, a solution has not yet been worked out which allows the exercise
price to be stochastic.
As Cox and Ross pointed out, the market equilibrium solution is independent of A, the process intensity.

This is because within the hedge portfolio

of stock and option postulated for the arbitrageur, jumps cancel each other
out.

It is not the frequency of jumps but the size of them which determines

the option's value within such a hedge.
uncertainty about the jump amplitude.

This presents a problem when there is
As pointed out in the discussion of

FOOTNOTES

l.

Source: National Science Foundation report, "National Patterns of R&D Resources, 1953-1977." The 1977 total was estimated at $40.8 billion,up 9%
from the $37.3 billion in 1976. Of the total, $5.2 billion was for basic
research, $9.0 billion for applied research, and $26.6 billion for development. Of the total estimate, 53% was for federally-funded projects --the
majority devoted to space and defense.

2.

Source:
64.

3.

See Branch 17), Clarkson [9), Grabowski & Mueller [24), Leonard [29),
Scherer [43), Schwartzman [47), Severn& Laurence [48), and Worley [53).

4.

See Baker and Freeland [4), p. 1169, "In summary, despite the large number
of benefit measurement models in the literature, relatively little is known
about the performance of these models when applied within an R&D environment. This is a critical area for future research."

5.

The risk-free rate is recommended here because risk is being handled through
the OPM. The money committed to research represents a voluntary obligation, and the amount of the outflow is assumed to be fixed ahead of time
with certainty.

6.

Perhaps the best published review is that by Clifford Smith [51).

7.

See data in note 1. Of the 1977 total, 65% was for product development;
only 12.7% was for basic research.

8.

The uncertainty about the exercise price arises from technological matters.
There is little ~ priori reason to believe that there should be a systematic relationship between such things and the market as a whole.

9.

See Baker & Freeland [4), p. 1165, where available models were criticized for "no explicit recognition and incorporation of the experience and
knowledge of the R&D manager."

Business Week survey published in the June 27, 1977 issue, pp. 62-

10.

See Smith [51] for proof.

11.

That is, all the company stands to lose is the research investment.
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